ロード中...

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's disease. Several studies reported associations of dopaminergic genes with the occurrence of adverse events of dopaminergic treatment. However, none of these studies adopted a pathway based approach. The aim of...

詳細記述

保存先:
書誌詳細
出版年:Front Pharmacol
主要な著者: Redenšek, Sara, Flisar, Dušan, Kojović, Maja, Gregorič Kramberger, Milica, Georgiev, Dejan, Pirtošek, Zvezdan, Trošt, Maja, Dolžan, Vita
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360186/
https://ncbi.nlm.nih.gov/pubmed/30745869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00008
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!